(13-02-2012, 09:31 AM)dzwm87 Wrote: surprising fall on its price. think there was too much bullishness and expectation on CMZ?
From
Lim and Tan,
2Q ended Dec ’11 bottom-line rise of 12% to Rmb175mln was slower than top-line growth of 19.4% to Rmb651mln as higher SG&A and finance expenses and fair value loss on biological assets cased a drag on margins. If not for the halving in tax rate to 7%, bottom-line performance would have been worst.
2Q’s 12% yoy net profit growth represents a sharp slowdown from 1Q’s 78% growth as the high base effect kicks in.
We believe 2Q’s performance was slightly below expectations.
Looking ahead, management expects to continue to benefit from the government’s efforts to become self sufficient with producing their own vegetables for internal consumption and the continued urbanization in China. The increased health awareness in China as well as overseas will continue to underpin demand for vegetables, especially with their increased focus on higher margined organic vegetables, king oyster mushrooms and black fungus.
The recently opened new production facility in Fujian helping to increase their capacity by 3x will come in handy as demand continues to climb and management expects the new facilities to achieve full utilization within the new few years.
Given the slightly weaker than expected 2Q performance we believe there may be some downward adjustments from the street.
While we continue to like the company for its exposure to an industry that is well supported by the Chinese government, given its
strong run-up ahead of its results (from the 90 cents level just a week ago) and slightly weaker than expected performance, we prefer to buy the stock on some price weakness below the $1 level.